0JW9.L
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors. It also engages in digital asset treasury management. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Industry
Medical - Pharmaceuticals
IPO Date
2018-01-29
Stock Exchange
LSE
Ticker
0JW9.L
According to Lite Strategy, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.25. This represents a change of 38.60% compared to the average of -2.34 of the last 4 quarters.
The mean historical PE Ratio of Lite Strategy, Inc. over the last ten years is -0.24. The current -3.25 PE Ratio has changed 137.15% with respect to the historical average. Over the past ten years (40 quarters), 0JW9.L's PE Ratio was at its highest in in the September 2020 quarter at 123.48. The PE Ratio was at its lowest in in the March 2017 quarter at -20.25.
Average
-0.24
Median
-1.81
Minimum
-10.66
Maximum
33.06
Discovering the peaks and valleys of Lite Strategy, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 161.63%
Maximum Annual PE Ratio = 33.06
Minimum Annual Increase = -1583.03%
Minimum Annual PE Ratio = -10.66
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -1.03 | -196.63% |
| 2024 | 1.07 | -177.61% |
| 2023 | -1.38 | -1.24% |
| 2022 | -1.39 | -82.06% |
| 2021 | -7.77 | -2.50% |
| 2020 | -7.97 | -25.25% |
| 2019 | -10.66 | 161.63% |
| 2018 | -4.07 | -112.32% |
| 2017 | 33.06 | -1583.03% |
| 2016 | -2.23 | 51.24% |
The current PE Ratio of Lite Strategy, Inc. (0JW9.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.45
5-year avg
-2.10
10-year avg
-0.24
Lite Strategy, Inc.’s PE Ratio is less than Sorrento Therapeutics, Inc. (-0.00), greater than FibroGen, Inc. (-16.47), less than Affimed N.V. (-0.08), less than Unity Biotechnology, Inc. (-0.12), less than Insight Molecular Diagnostics Inc. (-0.03), less than Q32 Bio Inc. (-0.97), less than Atara Biotherapeutics, Inc. (30.16), less than KALA BIO, Inc. (-0.18), greater than Palatin Technologies, Inc. (-4.65), greater than Sarepta Therapeutics, Inc. (-8.08),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.00 | N/A | |
| -16.47 | N/A | |
| -0.08 | N/A | |
| -0.12 | N/A | |
| -0.03 | N/A | |
| -0.97 | N/A | |
| 30.16 | N/A | |
| -0.18 | N/A | |
| -4.65 | N/A | |
| -8.08 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lite Strategy, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lite Strategy, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Lite Strategy, Inc.'s PE Ratio?
How is the PE Ratio calculated for Lite Strategy, Inc. (0JW9.L)?
What is the highest PE Ratio for Lite Strategy, Inc. (0JW9.L)?
What is the 3-year average PE Ratio for Lite Strategy, Inc. (0JW9.L)?
What is the 5-year average PE Ratio for Lite Strategy, Inc. (0JW9.L)?
How does the current PE Ratio for Lite Strategy, Inc. (0JW9.L) compare to its historical average?